Reuters Market Eye – Sunshine Pharmaceutical Industries drops 0.6 pct after Sept-qtr earnings. Sunlight’s Q2 earnings increased by 15 pct to 15.72 billion rupees. Earnings were in line with estimates regardless of hopes of a far better program after system Taro Pharmaceutical Industries reported higher incomes earlier – investors. Taro’s quarterly revenue increased by 49 pct to a document degree of $143 mln. Profit-taking also viewed as the Sunlight Pharma stock hit a document high of 932.50 rupees previously today. (Reporting by Abhishek Vishnoi)FinanceInvestment & & Business Info